J. Schüller

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

F. Anthony Greco, Robert A. Figlin, Martin York et al. · Journal of Clinical Oncology · 1996 · 78 citations

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.

D. Schrijvers, Jonas T. Johnson, U Jiminez et al. · Journal of Clinical Oncology · 1998 · 70 citations

Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.

Maurizio D’Incalci, J. Schüller, Tina Colombo et al. · PubMed · 1998 · 42 citations

Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil.

J. Schüller, Martin Czejka, G Schernthaner et al. · PubMed · 1992 · 29 citations

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study

Cornelis J.A. Punt, H.J. Keizer, J. Douma et al. · Annals of Oncology · 2002 · 27 citations · Full text

Medicine, Pharmacology, Colorectal Cancer +7